Cardiovascular Disease and Sex

One of the primary causes of death worldwide is cardiovascular disease (CVD). Women typically have a lower incidence of CVD than men, however after acute cardiovascular events, women have a higher mortality and worse prognosis. Different CVDs, such as coronary heart disease, stroke, heart failure, and aortic diseases, exhibit these sex variances. These differences have raised serious concerns so sex consideration is significant for the prevention, diagnosis, treatment, and management of CVD. In order to highlight the need of taking sex differences into account when determining cardiovascular risk, this study seeks to offer an overview of sex-related differences in numerous common CVDs as well as an analysis of potential factors linked with the disparities. Future studies should focus on how to define and include sex-related indicators into the methods currently used for cardiovascular risk assessment and management.

[1]  I. Zeljković,et al.  Acute Occlusion of the Infarct-Related Artery as a Predictor of Very Long-Term Mortality in Patients with Acute Myocardial Infarction , 2021, Cardiology research and practice.

[2]  Deepak L. Bhatt,et al.  2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2020, European heart journal.

[3]  F. Ruschitzka,et al.  Takotsubo Recurrence: Morphological Types and Triggers and Identification of Risk Factors. , 2019, Journal of the American College of Cardiology.

[4]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association , 2019, Circulation.

[5]  Akshay S. Desai,et al.  Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women. , 2019, Journal of the American College of Cardiology.

[6]  N. Brunetti,et al.  Takotsubo syndrome: State-of-the-art review by an expert panel - Part 1. , 2019, Cardiovascular revascularization medicine : including molecular interventions.

[7]  Susanna Price,et al.  2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. , 2018, European heart journal.

[8]  E. Unger,et al.  Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs. , 2018, Journal of the American College of Cardiology.

[9]  Theresa M. Beckie,et al.  Cardiovascular Disease and Breast Cancer: Where These Entities Intersect A Scientific Statement From the American Heart Association , 2018, Circulation.

[10]  G. Hindricks,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[11]  V. Salomaa,et al.  Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe) , 2017, Circulation.

[12]  S. James,et al.  Gender differences in coronary angiography, subsequent interventions, and outcomes among patients with acute coronary syndromes , 2017, American heart journal.

[13]  P. Giorgini,et al.  Gender differences in cardiovascular prophylaxis: Focus on antiplatelet treatment , 2017, Pharmacological research.

[14]  E. Blackstone,et al.  Does a similar procedure result in similar survival for women and men undergoing isolated coronary artery bypass grafting? , 2017, The Journal of thoracic and cardiovascular surgery.

[15]  S. Daskalopoulou,et al.  Sex differences in prodromal symptoms in acute coronary syndrome in patients aged 55 years or younger , 2016, Heart.

[16]  S. Marzolini,et al.  Sex Differences in Cardiac Rehabilitation Adherence: A Meta-analysis. , 2016, The Canadian journal of cardiology.

[17]  A. Tomaszuk-Kazberuk,et al.  Takotsubo cardiomyopathy: serious early complications and two-year mortality – a 101 case study , 2016, Netherlands Heart Journal.

[18]  Harlan M Krumholz,et al.  Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association , 2016, Circulation.

[19]  Bonnie Ky,et al.  Cancer Therapy–Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging , 2016, Circulation. Heart failure.

[20]  É. Marijon,et al.  Gender and survival after sudden cardiac arrest: A systematic review and meta-analysis. , 2015, Resuscitation.

[21]  E. Grafstein,et al.  There Are Sex Differences in the Demographics and Risk Profiles of Emergency Department (ED) Patients With Atrial Fibrillation and Flutter, but no Apparent Differences in ED Management or Outcomes. , 2015, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[22]  G. Ewald,et al.  Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). , 2015, Journal of the American College of Cardiology.

[23]  R. Arena,et al.  Cardiac rehabilitation referral, attendance and mortality in women , 2015, European journal of preventive cardiology.

[24]  Andrew E Moran,et al.  Demographic and epidemiologic drivers of global cardiovascular mortality. , 2015, The New England journal of medicine.

[25]  H. Krumholz,et al.  Symptom Recognition and Healthcare Experiences of Young Women With Acute Myocardial Infarction , 2015, Circulation. Cardiovascular quality and outcomes.

[26]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[27]  M. Cerqueira,et al.  Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2014, European heart journal cardiovascular Imaging.

[28]  G. Kocabay,et al.  An unusual presentation of peripartum cardiomyopathy: Recurrent transient ischemic attacks. , 2014, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[29]  A. Prasad,et al.  Diagnosis of Takotsubo cardiomyopathy. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[30]  A. Lyon,et al.  Pathophysiology of Takotsubo Syndrome , 2014 .

[31]  C. Murray,et al.  Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.

[32]  Erling Falk,et al.  Update on acute coronary syndromes: the pathologists' view. , 2013, European heart journal.

[33]  T. Marwick,et al.  Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. , 2013, Journal of the American College of Cardiology.

[34]  G. Lip,et al.  Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM). , 2012, The American journal of cardiology.

[35]  Adrian F Hernandez,et al.  Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction: Prevalence, Therapies, and Outcomes , 2012, Circulation.

[36]  Mike Kirby,et al.  ESC Guidelines on the Management of Cardiovascular Diseases During Pregnancy , 2012 .

[37]  U. Elkayam.  Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. , 2011, Journal of the American College of Cardiology.

[38]  U. Elkayam,et al.  Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection? , 2009, Autoimmunity reviews.

[39]  K. Schulman,et al.  Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. , 2007, JAMA.

[40]  V. Roger,et al.  Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.

[41]  I. V. Van Gelder,et al.  Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. , 2005, Journal of the American College of Cardiology.

[42]  C. Fonseca,et al.  Prevalence of chronic heart failure in Southwestern Europe: the EPICA study , 2002, European journal of heart failure.

[43]  P. Pepe,et al.  Sex-related differences in the presentation and outcome of out-of-hospital cardiopulmonary arrest: A multiyear, prospective, population-based study , 2002, Critical care medicine.

[44]  R. Virmani,et al.  Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. , 1998, Circulation.

[45]  E. Cook,et al.  Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  Deepak L. Bhatt,et al.  Predictors of adherence to performance measures in patients with acute myocardial infarction. , 2013, The American journal of medicine.

[47]  M. Roe,et al.  Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). , 2009, American heart journal.